Understanding the origin of the nucleon mass is one of the major scientific goals of the Electron-Ion Collider (EIC). Scientists also want to understand how the mass from quarks and gluons is ...

The patent recognizes IonQ's unique method for controlling the individual laser beams that are trapping its ion -- both upon entry and exit. Whereas previous techniques offered control in only one ...

At Ethereum's Devcon conference in Bangkok on Tuesday, Ethereum Foundation researcher Justin Drake revealed his proposal for a major redesign of Ethereum's consensus layer called "Beam Chain." ...

Once adjusted to remove any effects due to inflation, "real GDP" is revealed. Calculating GDP Based on Spending One way of arriving at GDP is to count up all of the money spent by the different ...

No longer a world-class contender in events that were traditionally its strength, China's figure skating national program is bracing itself for a bleak Winter Olympic campaign in Italy, yet ...

“There isn’t any place to walk to.” Determining whether an older person remains safe to drive has become a third rail of aging as many people maintain their license far longer than most did ...

Scientists have discovered a new way of creating superheavy elements by firing supercharged ion beams at dense atoms. The team believes this method could potentially help synthesize the ...

It started with, "When baba did that interview, I was very lost in life and I still laugh with joy at the honesty with which he said "my son is not figuring out" when @rajeevmasand started asking ...

With significant involvement in meticulous optomechanical assembly, design, and fabrication, Avantier is a reliable partner in key space programs globally. Avantier’s space optics solutions ...

Scientists have demonstrated a new way to use high-energy particle smashups at the Relativistic Heavy Ion Collider (RHIC ... the Facility for Rare Isotope Beams, a DOE Office of Science user ...

Beam Ther­a­peu­tics gave an ini­tial look at the first hand­ful of pa­tients who re­ceived its ex­per­i­men­tal gene-edit­ed treat­ment for sick­le cell dis­ease.